N
Newronika
Biotech & Life Sciences · Cologno Monzese, Italy · Founded 2016
Restores brain and body functions with neural devices based on biosignal decoding MoreLess
Developer of a neuro-modulation device designed to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve their quality of life. Keywords: Healthcare Devices, Services, Supplies, Brain Devices, Deep Brain Stimulation, Mental Fitness, Neuro Therapy, Neuromodulation Therapy, Therapeutic Instruments.
Company overview
Newronika company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Cologno Monzese, Italy
- Employees
- 25
- Open positions
- None listed
- Dealroom signal
- 69.8
Valuation & funding
Newronika funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2025 | $15M | $60M | Innogest Capital · Wille Finance · Indaco Venture Partners · TNBT Capital | ↗ |
| SUPPORT PROGRAM✓Other financing | Jan 2025 | $0 | — | EIT Health | — |
| EARLY VC✓Equity / VC | Oct 2022 | $0 | — | EIC Fund | — |
| GRANT✓Other financing | Oct 2022 | $2.5M | — | European Innovation Council | — |
| EARLY VC✓Equity / VC | Sep 2019 | $9.2M | $37M | Indaco Venture Partners · Innogest Capital · Omnes Capital | ↗ |
| SEED✓Equity / VC | Dec 2017 | Innogest Capital | — | ||
| SEED✓Equity / VC | Jul 2017 | Innogest Capital | — | ||
| SEED✓Equity / VC | Feb 2017 | Innogest Capital | — | ||
| SEED✓Equity / VC | Jun 2016 | Atlas Venture · Atlante Ventures · Innogest Capital · Intesa Sanpaolo | ↗ | ||
| SPINOUT✓Other financing | Jan 2016 | University of Milan | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Newronika website traffic
Latest recorded traffic for Newronika is 1.3K monthly website visits, up 550% over the last three months. Newronika's team declined 7.4% over the past year.
Comparisons
Newronika compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Newronika's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Newronika has talent and traffic
team presence
In the news
Latest news about Newronika
Recent press, funding announcements, and product moves mentioning Newronika — open to read from the original sources.
Market sentiment
What the market is saying about Newronika
An AI-synthesized read of the highest-engagement posts about Newronika on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Newronika’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.